OS2966 DRAMATICALLY ENHANCES PRECLINICAL EFFICACY OF ONCOLYTIC VIRUS THERAPY

被引：0
|
作者：
Carbonell, Shawn [1 ]
Yoo, Ji Young [2 ]
Nallanagulagari, Tejaswini [2 ,3 ]
Jaime-Ramirez, Alena Cristina [2 ]
Bolyard, Chelsea [2 ]
Lee, Tae Jin [4 ]
Zhang, Jianying [5 ]
Croce, Carlo [4 ]
Wu, Eric [1 ]
Aghi, Manish [6 ]
Kaur, Balveen [2 ]
机构：
[1] OncoSynergy Inc, San Francisco, CA USA
[2] Ohio State Univ, Coll Med, Dept Neurol Surg, Dardinger Lab Neurooncol & Neurosci, Columbus, OH 43210 USA
[3] Ohio State Univ, Biochem & Microbiol Majors, Columbus, OH 43210 USA
[4] Ohio State Univ, Wexner Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA
[5] Ohio State Univ, Dept Biomed Informat, Ctr Biostat, Columbus, OH 43210 USA
[6] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA
来源：
NEURO-ONCOLOGY | 2016年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EXTH-33
引用
收藏
页码：66 / 66
页数：1
相关论文
共 50 条
  • [1] OS2966 DRAMATICALLY ENHANCES PRECLINICAL EFFICACY OF ONCOLYTIC VIRUS THERAPY
    Carbonell, Shawn
    Yoo, Young
    Nallanagulagari, Tejaswini
    Jaime-Ramirez, Alena Cristina
    Bolyard, Chelsea
    Lee, Tae Jin
    Zhang, Jianying
    Croce, Carlo
    Wu, Eric
    Aghi, Manish
    Kaur, Balveen
    NEURO-ONCOLOGY, 2016, 18 : 66 - 66
  • [2] Enhancing Therapeutic Efficacy of an Oncolytic Virus with a Beta-1 Integrin Blocking Antibody, OS2966
    Nallanagulagari, Tejaswini Reddy
    MOLECULAR THERAPY, 2016, 24 : S260 - S261
  • [3] Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus-1 with Integrin β1 Blocking Antibody OS2966
    Lee, Tae Jin
    Nair, Mitra
    Banasavadi-Siddegowda, Yeshavanth
    Liu, Joseph
    Nallanagulagari, Tejaswini
    Jaime-Ramirez, Alena Cristina
    Guo, Jeffrey Yunhua
    Quadri, Haroon
    Zhang, Jianying
    Bockhorst, Kurt H.
    Aghi, Manish K.
    Carbone, W. Shawn
    Kaur, Balveen
    Yoo, Ji Young
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (06) : 1127 - 1136
  • [4] COMBINATION OF oHSV WITH INTEGRIN β1 NEUTRALIZING ANTIBODY (OS2966) AUGMENTS oHSV THERAPY
    Yoo, Ji Young
    Banasavadi-Siddegowda, Yeshavanth Yeshavanth
    Relation, Theresa
    Aghi, Manish
    Kaur, Balveen
    NEURO-ONCOLOGY, 2014, 16
  • [5] IL-12 Enhances the Efficacy of Oncolytic Adenoviral Therapy in an Immunocompetent Preclinical Model of Prostate Cancer
    Ternovoi, Vladimir V.
    Zhang, Yingshu
    Barton, Kenneth N.
    Freytag, Svend O.
    MOLECULAR THERAPY, 2009, 17 : S214 - S215
  • [6] Modulation of tumor microenvironment enhances oncolytic virus therapy
    Kurozumi, Kazuhiko
    Hardcastle, Jayson
    Yang, Ming
    Christoforidis, Gregory
    Carson, William
    Chiocca, Antonio
    Kaur, Balveen
    JOURNAL OF NEURO-ONCOLOGY, 2008, 87 (02) : 209 - 210
  • [7] Assessing the Completeness of Reporting in Preclinical Oncolytic Virus Therapy Studies
    Fergusson, Dean A.
    Wesch, Neil L.
    Leung, Garvin J.
    MacNeil, Jenna L.
    Conic, Isidora
    Presseau, Justin
    Cobey, Kelly D.
    Diallo, Jean-Simon
    Auer, Rebecca
    Kimmelman, Jonathan
    Kekre, Natasha
    El-Sayes, Nader
    Krishnan, Ramya
    Keller, Brian A.
    Ilkow, Carolina
    Lalu, Manoj M.
    MOLECULAR THERAPY-ONCOLYTICS, 2019, 14 : 179 - 187
  • [8] Advances in preclinical and clinical studies of oncolytic virus combination therapy
    Du, Wenlong
    Na, Jintong
    Zhong, Liping
    Zhang, Pumin
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [9] Expression of IFN-β Enhances Both Efficacy and Safety of Oncolytic Vesicular Stomatitis Virus for Therapy of Mesothelioma
    Willmon, Candice L.
    Saloura, Vassiliki
    Fridlender, Zvi G.
    Wongthida, Phonphimon
    Diaz, Rosa Maria
    Thompson, Jill
    Kottke, Timothy
    Federspiel, Mark
    Barber, Glen
    Albelda, Steven M.
    Vile, Richard G.
    CANCER RESEARCH, 2009, 69 (19) : 7713 - 7720
  • [10] Neutralization of matrix metalloproteinase-9 potentially enhances oncolytic efficacy of tanapox virus for melanoma therapy
    Tiantian Zhang
    Yogesh R. Suryawanshi
    Blair R. Szymczyna
    Karim Essani
    Medical Oncology, 2017, 34
12345